Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry, v3.3.2, was added to the history. The older revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check27 days agoChange DetectedThe notice about government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedAn additional Study Status entry appears in the record history (version 18) dated around 2025-10-30/31. This indicates an update to the trial’s current status.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check78 days agoChange DetectedUpdate: Revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.7%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.